ACE and atrial fibrillation: It should be further noted that clinical trials and case-control analyses have not found BBs and CCBs to be consistently superior to other drug classes including angiotensin receptor blockers and angiotensin-converting enzyme inhibitors when examining impact on AF burden.10,11,38